Related Experiment Video
Updated: Oct 10, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Aortic valve replacement with and without concomitant coronary artery bypass surgery in the elderly: risk factors
1Department of Cardiothoracic Surgery, Lund University Hospital, SE-221 85 Lund, Sweden. lars_thulin@hotmail.com
Insights
Aortic valve replacement (AVR) in elderly patients (>75 years) shows excellent surgical outcomes. Concomitant coronary artery bypass grafting (CABG) did not negatively impact long-term survival in this population.
Area of Science:
- Cardiology
- Cardiac Surgery
- Geriatric Medicine
Background:
- Elderly patients (>75 years) undergoing aortic valve replacement (AVR) frequently have significant coronary artery lesions.
- The benefit of concurrent coronary artery bypass grafting (CABG) with AVR in this age group remains debated.
Purpose of the Study:
- To evaluate the long-term survival outcomes of elderly patients undergoing AVR with or without concomitant CABG.
- To determine if concomitant CABG influences surgical outcomes in elderly AVR patients.
Main Methods:
- Retrospective analysis of 219 patients aged 75+ undergoing AVR between 1990-1993.
- Patients were divided into AVR alone (n=121) and AVR with CABG (n=98) groups.
- Long-term survival was assessed using Kaplan-Meier analysis and Cox-Mantel log-rank tests.
Main Results:
- Early mortality was 0.8% for AVR and 4.1% for AVR+CABG.
- Overall actuarial survival at 52 months was 77.7%.
- Mechanical valve implantation in the AVR group was associated with significantly longer survival; concomitant CABG did not significantly affect long-term survival.
Conclusions:
- Aortic valve replacement in the elderly is a safe procedure with favorable surgical results.
- Concomitant coronary artery bypass grafting is not identified as a predictor of poor long-term surgical outcome in elderly patients undergoing AVR.
Aim:
Preoperative coronary angiography often reveals significant coronary artery lesions in elderly people (>75 years of age) referred to hospital for aortic valve replacement (AVR). However, the possible benefit of concomitant coronary artery bypass grafting (CABG) in elderly is still under debate. In an effort to contribute to this discussion, we evaluated our data on elderly patients after aortic valve replacement.
Methods:
Between January 1990 and December 1993, 219 patients, aged 75 years and older, underwent AVR with or without concomitant CABG at our Department. There were 121 patients in the AVR group and 98 patients in the AVR+CABG group. There was no significant difference between the two groups in their age, sex valve type, valve size, and presence of diabetes. Five variables (concomitant CABG, age, sex, and type and size of prosthesis) were investigated with regard to long-term survival assessed by the Kaplan-Meier analysis. Group comparisons of survival were made with the Cox-Mantel log-rank test.
Results:
Early mortality (<30 days) was 0.8% in the AVR group and 4.1% in the AVR+CABG group. Overall actuarial survival was 77.7+/-4.4% at 52 months. There was significantly longer survival in patients with mechanical valve implant in the AVR group. None of the other 5 investigated variables had a significant influence on the long-term survival.
Conclusion:
Our results suggest that AVR done in elderly is a treatment with excellent surgical results. We could not identify concomitant CABG as a predictor of poor long-term surgical outcome.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation IV: Nursing Management

